Article Image
News Link • Science, Medicine and Technology

HIV Protection Achieved

• arclein
he results were similar to those from another trial, conducted jointly by the US Centers for Disease Control and the Botswana Ministry of Health. In this study, 1200 HIV-negative, sexually active people from Botswana received either Truvada or a placebo daily. Over two years, only nine people taking Truvada became infected, compared with 24 in the placebo group – a 63 per cent reduction in risk.

Join us on our Social Networks:


Share this page with your friends on your favorite social network: